由ALK重组和EGFR野生型肺腺癌转化为小细胞肺癌:一个病例报告

Rui Chen1, Yan Jian2, Yuzhen Liu3

  • 1Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.

PubMed
概括

罕见的ALK重组肺腺癌转化为小细胞肺癌,突出了对ALK-TKI的耐药性. 重复活检对于适应晚期肺癌治疗至关重要.